| Prev Close | 222.23 |
| Open | 224.74 |
| Day Low/High | 212.65 / 230.82 |
| 52 Wk Low/High | 66.23 / 253.00 |
| Volume | 2.21M |
Teladoc Health, Inc. (TDOC)
216.77
5.46
2.46
NYSE
| Exchange | NYSE |
| Shares Outstanding | 81.23B |
| Market Cap | 18.17B |
| P/E Ratio | N/A |
| Div & Yield | N.A. (N.A) |
Latest News
7 High-Tech Winners in Medical Diagnostics and Devices
These names combine healthcare research with state-of-the art technology.
You Can Get Hurt Falling From High Places
Beware of high-flying stocks and instead opt for these 'grounded' ones.
What to Expect From Livongo Health Now
Livongo recently agreed to merge with Teladoc Health.
Should Investors Log In to Teladoc?
It might be a good time to buy the stock because of its recent pullback, but there also is an ETF traders might consider if the telemedicine sector is of interest.
Jim Cramer: No Shinola! Sellers Are Wrong on These 3 Stocks
Wendy's, Regeneron and Teladoc -- why would you unload them now?
Teladoc Looks Like a Tough Call
Could the charts be anticipating a peak in Teladoc health? Here's my strategy for this one.
I Wouldn't Buy Pfizer Shares on This Pop
I would wait until the next down day, and there will be one.
2 Stocks to Put on Your Radar
I wouldn't look at Alkaline Water and Sprouts Farmers Market for a trade, but as speculative buy 'em and forget 'em for the summer.
If You Can't Answer This One Question, You Shouldn't Own the Russell 2000
Think you're diversified? Understanding what you are investing and trading in is key.
Here Are 7 Earnings Reports to Watch for After Wednesday's Close
Let's get our ducks in order as there are a number of high-profile earnings reports coming at us after today's market rings the closing bell. Here are some things to watch and consider from the reports that are likely to garner investor attention: ...
Earnings in Full Swing, Workplace Evolution, Fed Day
There was a mild increase in trading volume at the New York Stock Exchange, but it was a rotational shift.
Let's Go Trend Spotting
Intraday trends -- relentless trends -- are becoming the name of the game, so let's focus on the rotation from Nasdaq names into the Russell 2000 and financials.
These Stocks and Sectors Should Hold Up Well Despite Covid-19
It is worth tracking these three names.
Maintaining Optimism in a Surreal Pandemic Environment
I never understood why my state of Florida, with vastly fewer deaths, is on the same sort of lockdown as New York.
I Feel Like a Longer View Put Spread With Chewy Might be a Logical Play
I would want to give this trade either a long time or look for a quick drop.
My New Multi-Group Portfolio Strategy for Trading the Pandemic
How has my book evolved since the Fed and Treasury rode into town? Here's how.
Has This Counter-Trend Bounce Run Out of Steam?
I see no reason to build any longer-term positions but there are trades to be had.
6 'Work-At-Home' and Telemedicine Stocks You Should Know About
These names should do well as long as the coronavirus is a threat, and still continue to grow once it is past.
Here Are My 7 Takeaways Heading Into Q2
It's still not a stock picker's market, but have a list of names ready to perform amid the coronavirus crisis.
Jim Cramer: Microsoft Has Been the Biggest Beneficiary of the Moment
Now the one thing you need to worry about with MSFT, as you have to do with all of the techies, is the GDP.
In a Post-Coronavirus World, Put This Lesser-Known Stock on Your List
Things will be different after Covid-19 and one change will be in how people care about themselves.
3 Stocks to Own Now: HUYA, Chewy, and Fastly
All three are names that can survive if the shelter-in-place order in various areas in the United States extends post-Easter, and they'll benefit beyond COVID-19.
A Look at Our Situation Now: Good, Bad, and Ugly, and 3 New Stock Groups
Consider these stock model ideas: virus groups, work remotely, and fiscal.
Teladoc Health Is Rising Strongly With Very Healthy Technical Indicators
TDOC is in the driver's seat with a strong technical picture and much higher price targets.
Here's My Watchlist of 12 Covid-19 Stock Plays
If this group begins to outperform, then I'd use it as an indication of caution.
These Are the Times We Live In
Here again is my approach and my three stock groups: 'rebound', 'revenue' and 'virus'.
Teladoc Health Is Blazing the Way Higher
Traders need to focus on the trend.
